Carcinoma, Embryonal
Showing 1 - 25 of 7,699
Molecular Epidemiology of Pediatric Germ Cell Tumors
Recruiting
- Germ Cell Tumor
- +8 more
- Questionnaire Administration
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 22, 2022
Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors Trial run by the National
Not yet recruiting
- Adenocarcinoma of the Bladder
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)
Recruiting
- Liver Cell Carcinoma
- +7 more
- CATCH T cells
- +2 more
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)
Active, not recruiting
- Sarcoma
- +6 more
-
Villejuif, FranceGustave Roussy Cancer Campus
Mar 28, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Pralsetinib to Best Available Therapy in RET-Fusion Positive
Enrolling by invitation
- RET-fusion Non Small Cell Lung Cancer
- +16 more
-
New York, New York
- +2 more
Aug 9, 2021
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)
Recruiting
- Late Effects
- +8 more
- PASCA intervention
-
Lyon, FranceCentre Leon Berard
Mar 15, 2022
CNS Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma Trial in Australia, Canada, United States (drug,
Recruiting
- Central Nervous System Nongerminomatous Germ Cell Tumor
- +9 more
- Carboplatin
- +10 more
-
Little Rock, Arkansas
- +60 more
Aug 17, 2022
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Trained Immunity in Thyroid Carcinoma and Colon Carcinoma
Recruiting
- Thyroid Cancer, Nonmedullary
- Colon Carcinoma
- no intervention will take place
-
Nijmegen, Gelderland, NetherlandsRadboudUMC
Sep 21, 2022
Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor, Stage IV Ovarian Epithelial Cancer Trial in Seattle
Completed
- Stage III Ovarian Epithelial Cancer
- +3 more
- pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine
- laboratory biomarker analysis
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 22, 2021
Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor Trial in Worldwide (other, biological,
Recruiting
- Childhood Extracranial Germ Cell Tumor
- +30 more
- Best Practice
- +12 more
-
Birmingham, Alabama
- +579 more
Jan 30, 2023
Germ Cell Tumors, Testis Cancer, Testicular Cancer Trial in Los Angeles, Indianapolis, New York (Brentuximab Vedotin)
Terminated
- Germ Cell Tumors
- +4 more
- Brentuximab Vedotin
-
Los Angeles, California
- +3 more
Dec 3, 2019
Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor Trial in Worldwide
Completed
- Childhood Embryonal Tumor
- +17 more
- conventional surgery
- +4 more
-
Birmingham, Alabama
- +125 more
Jul 9, 2021
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Testicular Cancer Trial (Analysis of biological samples of saliva from testicular cancer patients and from their first-degree
Not yet recruiting
- Testicular Cancer
- Analysis of biological samples of saliva from testicular cancer patients and from their first-degree family members
- (no location specified)
Nov 16, 2023
Saliva or Buccal Mucosa Samples From Embryonal or Alveolar
Recruiting
- Alveolar Rhabdomyosarcoma
- Embryonal Rhabdomyosarcoma
- Biospecimen Collection
- +2 more
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 8, 2022
Yttrium-90 in Children, Adolescents, and Young Liver Tumors
Recruiting
- Hepatoblastoma
- +5 more
- Quality of Life Assessment
- Transarterial Radioembolization
-
Wilmington, Delaware
- +1 more
Apr 2, 2020
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022